BioSpace News Archive

Policy

Statement from the Chief Public Health Officer of Canada on June 7, 2020

In lieu of a daily in-person update to the media, Dr. Theresa Tam, Canada’s Chief Public Health Officer, issued the following statement

June 7, 2020
·
2 min read
Policy

Coronavirus (COVID-19) Update: FDA Reissues Emergency Use Authorizations Revising Which Types of Respirators Can Be Decontaminated for Reuse - June 07, 2020

In response to public health and safety concerns about the appropriateness of decontaminating certain respirators, the agency is reissuing certain emergency use authorizations to specify which respirators are appropriate for decontamination.

June 7, 2020
·
4 min read
Business

HitGen and Evotec SE Enter Into Drug Discovery Research Collaboration

HitGen announced that it has entered into a drug discovery research collaboration with Evotec SE to identify small molecule leads against targets of interest to Evotec SE in the field of anti-infectives.

June 7, 2020
·
3 min read
Drug Development

Junshi Biosciences Announces Dosing of First Healthy Volunteer in Phase I Clinical Study of SARS-CoV-2 Neutralizing Antibody JS016 in China

First healthy volunteer has been dosed in a Phase I study of JS016, the first SARS-CoV-2 neutralizing antibody to enter the clinical stage in China

June 7, 2020
·
6 min read
Drug Development

Alnylam Presents Positive Phase 3 Results from ILLUMINATE-A Study of Lumasiran, an Investigational RNAi Therapeutic for Treatment of Primary Hyperoxaluria Type 1

Lumasiran Achieved Primary Endpoint with 53.5 Percent Mean Reduction in Urinary Oxalate Relative to Placebo and Showed a 65.4 Percent Reduction Relative to Baseline

June 7, 2020
·
17 min read
Policy

VasQ™ External Support Awarded Breakthrough Device Designation by the FDA

The FDA has designated Laminate Medical’s VasQ™ External Support for the creation of arteriovenous fistulas in hemodialysis patients as a Breakthrough Device.

June 7, 2020
·
3 min read